English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/134376
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

AuthorsLabrador, Jorge; López-Anglada, Lucía; Lozano, Francisco S.; López-Corral, L.; Sánchez-Guijo, Fermín M.; Vázquez, Lourdes; Pérez-Rivera, José Ángel; Martin-Herrero, Francisco; Guerrero Arroyo, María del Carmen ; Cañizo, María Consuelo del; Caballero, Maria Dolores; San Miguel, Jesús F. ; González-Porras, José R.
Issue Date2013
PublisherFerrata Storti Foundation
CitationHaematologica 98(3): 437-443 (2013)
AbstractAllogeneic hematopoietic stem cell transplantation recipients have an increasing risk of both hemorrhagic and thrombotic complications. However, the competing risks of two of these life-threatening complications in these complex patients have still not been well defined. We retrospectively analyzed data from 431 allogeneic transplantation recipients to identify the incidence, risk factors and mortality due to thrombosis and bleeding. Significant clinical bleeding was more frequent than symptomatic thrombosis. The cumulative incidence of a bleeding episode was 30.2% at 14 years. The cumulative incidence of a venous or arterial thrombosis at 14 years was 11.8% and 4.1%, respectively. The analysis of competing factors for venous thrombosis revealed extensive chronic graft-versus-host disease to be the only independent prognostic risk factor. By contrast, six factors were associated with an increased risk of bleeding; advanced disease, ablative conditioning regimen, umbilical cord blood transplantation, anticoagulation, acute III-IV graft-versus-host disease, and transplant-associated microangiopathy. The development of thrombosis did not significantly affect overall survival (P=0.856). However, significant clinical bleeding was associated with inferior survival (P<0.001). In allogeneic hematopoietic stem cell transplantation, significant clinical bleeding is more common than thrombotic complications and affects survival.
DescriptionThis is an open-access paper.-- et al.
Publisher version (URL)http://dx.doi.org/10.3324/haematol.2012.069559
Identifiersdoi: 10.3324/haematol.2012.069559
issn: 0390-6078
e-issn: 1592-8721
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
431allogeneic.pdf466,3 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.